Unbiased AI-powered news
Blushing occurs when blood vessels in the face dilate in response to social situations, driven by the sympathetic nervous system. This response is involuntary and distinct from other autonomic reactions. Researchers have proposed theories linking blushing to social signaling and norm compliance in human groups.
Substrate placeholder — needs reviewBlushing is a physiological response that reddens the skin on the face, neck, and upper chest during certain social situations. Forbes reported on the mechanism and evolutionary theories behind this response, drawing from research by evolutionary biologists and psychologists.
At the biological level, blushing involves activation of the sympathetic nervous system, which governs fight-or-flight responses.
This response is involuntary and distinct from other autonomic reactions, as suggested by research in the field.
Several theories explain the evolution of blushing, focusing on its role in social interactions.
These frameworks are not mutually exclusive and address different aspects of social behavior in humans. Researchers have proposed ideas linking blushing to social signaling and norm compliance in human groups, such as signaling deference after social norm violations or aiding in reputation repair by appearing more trustworthy.
The involuntariness of the blush may enhance its reliability as a signal in social contexts.
These theories highlight blushing's potential function in maintaining group cohesion among humans as social animals.
Further research continues to explore these mechanisms, with implications for understanding emotional signaling across species. The studies emphasize the adaptive value of visible, uncontrollable responses in complex social environments.
The Ministry of Health reported 1,003 cases and 254 deaths as of the latest count, with 100 recoveries. The Bundibugyo virus outbreak, declared May 15 in Ituri province, has spread to neighboring provinces and Uganda.
entrepreneur.comAbbVie will pay $10.9 billion in cash to buy Apogee Therapeutics, a Waltham-based developer of immunology drugs. The deal values Apogee shares at $135.11 each, a roughly 50 percent premium to the prior close.
The IndependentRecord spring rains and snowmelt flooded northern Michigan homes, exposing gaps in federal flood maps and insurance access for thousands of residents. Many property owners had been told they were outside mapped flood zones and could not obtain coverage.